Submit Article
Back to Journal

SM Journal of Gynecology and Obstetrics

Essure

[ ISSN : 2573-6744 ]

Abstract
Details

Received: 31-Aug-2017

Accepted: 08-Feb-2018

Published: 02-Mar-2018

Review Article | Volume 4 - Issue 1 | Article DOI :

Download PDF

Carugno Jose¹, Andrade Fausto², and Laganà Antonio²*

¹ Obstetrics and Gynecology Department, University of Miami, Miller School of Medicine, USA
² Obstetrics and Gynecology Unit, Department of Human Pathology in Adulthood and Childhood “G. Baresi,” University of Messina, Italy

Corresponding Author:

Carugno Jose, Obstetrics and Gynecology Department. University of Miami. Miller School of Medicine. Miami, USA, Email: jac209@med.miami.edu

Abstract

Permanent sterilization is a very common form of family planning. Hysteroscopic sterilization has been an ongoing target for litigation, complaints and adverse publicity. To establish a positive correlation between Essure® insertion and any given side effect, it must be demonstrated that the incidence of the specific symptom is higher in patients who underwent Essure® insertion than in the general population. There are many confounders that must be taken into consideration before concluding that a given symptom is related to an intervention. A review of different clinical conditions regarding Essure® is presented.

Conclusion: Evidence based support linking the use of Essure® to adverse events is lacking when placed in appropriate selected candidates. Adequate patient selection and thorough inform consent is strongly encouraged before inserting Essure®.

Citation

Jose C, Fausto A and Antonio L. Essure® Permanent Sterilization. A not Evidence-Based Argument Controversy. SM J Gynecol Obstet. 2018; 4(1): 1026.